Published on 4 May 2022 on Simply Wall St. via Yahoo Finance
Shareholders in Lipocine (NASDAQ:LPCN) are in the red if they invested five years ago
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut when we see fellow investors suffer a loss. Imagine if you held Lipocine Inc. (NASDAQ:LPCN) for half a decade as the share price tanked 78%. And some of the more recent buyers are probably worried, too, with the stock falling 36% in the last year. Even worse, it's down 34% in about a month, which isn't fun at all.
Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business.
View our latest analysis for Lipocine